Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy.

about

BRCA2 mutations should be screened early and routinely as markers of poor prognosis: evidence from 8,988 patients with prostate cancer.Investigating BRCA Mutations: A Breakthrough in Precision Medicine of Castration-Resistant Prostate Cancer.

P2860

Q36347042-9F629BBB-79BF-4FA3-8410-575C3FDE984D Q38893354-C53DC35E-71FB-4589-80DA-BC51A8E657D8

P2860

Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy.

Item

http://www.wikidata.org/entity/Q48146508

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Overexpression of BRCA1 or BRC ...... e after radical prostatectomy.

@en

Overexpression of BRCA1 or BRC ...... e after radical prostatectomy.

@nl

type

Item

label

Overexpression of BRCA1 or BRC ...... e after radical prostatectomy.

@en

Overexpression of BRCA1 or BRC ...... e after radical prostatectomy.

@nl

prefLabel

Overexpression of BRCA1 or BRC ...... e after radical prostatectomy.

@en

Overexpression of BRCA1 or BRC ...... e after radical prostatectomy.

@nl

P1476

Overexpression of BRCA1 or BRC ...... ce after radical prostatectomy

@en

P2093

Geon Kook Lee

http://www.w3.org/2001/XMLSchema#string

Ho Kyung Seo

http://www.w3.org/2001/XMLSchema#string

Jae Young Joung

http://www.w3.org/2001/XMLSchema#string

Jinsoo Chung

http://www.w3.org/2001/XMLSchema#string

Jungnam Joo

http://www.w3.org/2001/XMLSchema#string

Kang Hyun Lee

http://www.w3.org/2001/XMLSchema#string

Soo In Yun

http://www.w3.org/2001/XMLSchema#string

Weon Seo Park

http://www.w3.org/2001/XMLSchema#string

P2860

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer.

Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer

Cancer susceptibility and the functions of BRCA1 and BRCA2

High-level expression of Rad51 is an independent prognostic marker of survival in non-small-cell lung cancer patients

Overexpression of RAD51 occurs in aggressive prostatic cancer

Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer

In search of the tumour-suppressor functions of BRCA1 and BRCA2

Identification of seven new prostate cancer susceptibility loci through a genome-wide association study

Hallmarks of 'BRCAness' in sporadic cancers

Cellular functions of the BRCA tumour-suppressor proteins.

P304

673-679

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/HIS.12809

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sung Han Kim

P577

2015-10-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26272590

http://www.w3.org/2001/XMLSchema#string

Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy.

about

P2860

P2860

Overexpression of BRCA1 or BRCA2 in prostatectomy specimens is predictive of biochemical recurrence after radical prostatectomy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698